Research

Research


Woke Pharmaceuticals has partnered with Associate Professor Scott Stewart at UWA and his research team to discover novel analogues of LSD  (lysergic acid diethylamide) for treatment of anxiety, substance abuse and other mental health disorders. Through novel chemistry, UWA and Woke Pharmaceuticals aim to solve some of the side-effect, toxicity, pharmacokinetic (absorption, distribution, metabolism, and excretion) challenges, that have limited the therapeutic application of LSD.


“The UWA team, led by A/Professor Stewart, has unique expertise in the chemical modification of LSD. The research will generate novel analogues that aim to improve the clinical utility of this psychedelic therapy.”